Plus LibraryBy pinki@katapult.biz / February 13, 2025 Speciality — Amyotrophic Lateral Sclerosis (ALS) Biomarkers Biosimilars Bladder Blood Bone Brain Breast Cancer Central Nervous System (CNS) Clinical Trials Colon Colorectal Diversity, Equity & Inclusion Featured Content Gastrointestinal Genitourinary Genomic Geriatric Gynecology Head and Neck Hematologic Hematologic Maglinencies Hematology Immunotherapy Interventional Radiology Kidney Leukemia Liquid Biopsy Liver Lung Lymphoma Malignencies Melanoma Myelodysplastic Syndrome Myeloma Neuroendocrine Novel Oral & Maxillofacial Surgery Ovarian Pancreas Pancreatic Pharmacological Prostate Radiation Radiology Renal Sarcoma Skin Solid Tumor Supportive & Palliative Care Survivorship Telemedicine Thoracic Thrombosis Thymic Thyroid Urothelial Author / Speaker Title of Presentation Type of Media — Video Document Audio Event 2024 Event — 2024 California Cancer Consortium Conference (CCC) 2024 MLS Cleveland 2024 MLS Nashville 2024 MLS New Orleans 2024 MLS Seattle 2024 New Orleans Summer Cancer Meeting (NOSCM) 2024 PRIMO 2024 SPS Puerto Rico 2024 SPS Seattle 2024 SPECTRUM 2024 Sylvester APP Oncology Symposium 2024 WCS 2024 MaTOS Lungs 2025 PRIMO Clear Displaying 1,901 - 1,925 of 2,875 « 1 … 75 76 77 78 79 … 115 » RET, MET & NTRK Mutations in NSCLC Mark Socinski, MD View Video RET, MET & NTRK Mutations in NSCLC Mark Socinski, MD View PDF EGFRex20ins, METex14 and RET in NSCLC Mark Socinski, MD View PDF EGFRex20ins, METex14 and RET in NSCLC Mark Socinski, MD View Video NTRK and Antibody Drug Conjugates in NSCLC Martin Dietrich, MD, PhD View PDF ALK, ROS-1 and RET Martin Dietrich, MD, PhD View PDF KRAS mutant NSCLC: What is the Standard of Care Now? Mary Jo Fidler, MD View PDF KRAS mutant NSCLC: What is the Standard of Care Now? Mary Jo Fidler, MD View Video Targeted Therapy Matthew Gubens, MD View PDF Mesothelioma and Thymoma – Limited and Advanced Stage Matthew Gubens, MD View PDF Mesothelioma and Thymoma – Limited and Advanced Stage Matthew Gubens, MD View PDF Targeted Therapy Matthew Gubens, MD View Video Mesothelioma and Thymoma – Limited and Advanced Stage Matthew Gubens, MD View Video Resistance to KRAS Inhibitors Matthew Gubens, MD View PDF Oncogene-Driven NSCLC Matthew Gubens, MD, MS View PDF Mesothelioma and Thymoma – Limited and Advanced Stage Matthew Gubens, MD, MS View Video Mesothelioma and Thymoma – Limited and Advanced Stage Matthew Gubens, MD, MS View PDF Mesothelioma and Thymoma – Limited and Advanced Stage Matthew Gubens, MD, MS View PDF Mesothelioma and Thymoma – Limited and Advanced Stage Matthew Gubens, MD, MS View Video What’s New in EGFR, ALK, RET and c-MET Matthew Gubens, MD, MS View PDF Assessing the Cancer Risk of Lung Nodules by Proteomic or Gene Expression Platforms Matthew Smeltzer, PhD View PDF Radiation in Early-Stage NSCLC Megan Daly, MD View PDF New Therapeutic Directions in Lung Cancer Megan Daly, MD View PDF Radiation in Early-Stage NSCLC Megan Daly, MD View PDF Radiation in Early-Stage NSCLC Megan Daly, MD View Video
